SXShun-Peng Xu

Shun-Peng Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shun-Peng Xu has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Hao-Jie Zhong

    Department of Gastroenterology, Research Center for Engineering Techniques of Microbiota-Targeted Therapies of Guangdong Province, the First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China

    1 shared publication
  • Ming-Fan Hong

    Department of Neurology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China

    1 shared publication
  • Xing-Xiang He

    Department of Gastroenterology, Research Center for Engineering Techniques of Microbiota‐Targeted Therapies of Guangdong Province The First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou China

    1 shared publication
  • Yi-Ting Zhang

    Department of Gastroenterology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, People’s Republic of China

    1 shared publication
  • Yu-Pei Zhuang

    The First Affiliated Hospital of Guangdong Pharmaceutical University

    1 shared publication

Latest Publications

  • Distinguishing between the complications of Wilson disease-related cirrhosis and HBV-related cirrhosis

    by Hao-Jie Zhong, Yu-Pei Zhuang, Yi-Ting Zhang, Shun-Peng Xu, Ming-Fan Hong, Xing-Xiang He

    Complications affect the outcome of patients with cirrhosis. The favorable prognosis of patients with Wilson disease (WD)-related cirrhosis suggests that its complications differ from those of hepatitis B virus (HBV) infection-related cirrhosis. We aimed to delineate the differences in complications between WD-related and HBV-related cirrhosis. The electronic-medical data from patients with WD-related and HBV-related cirrhosis were extracted and analyzed. In total, 211 patients with WD-related cirrhosis and 374 patients with HBV-related cirrhosis were enrolled. Most patients with WD progressed to cirrhosis 10 years. Patients with WD-related cirrhosis had a markedly lower prevalence of ascites (8.5% vs. 38.5%), gastroesophageal varices/variceal bleeding (13.3% vs. 47.6%), renal impairment (0 vs. 7.6%) and primary liver cancer (0 vs. 39.3%; all P < 0.001) than those with HBV-related cirrhosis. After adjustment for potential confounders, patients with WD-related cirrhosis carried a lower risk of varices/variceal bleeding. Although patients with WD progressed to cirrhosis much faster, the prevalence of complications from WD-related cirrhosis was low. Patients with WD-related cirrhosis were less likely to develop gastroesophageal varices/variceal bleeding than those with HBV-related cirrhosis.